Page last updated: 2024-09-03

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and divalinal-angiotensin iv

angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- has been researched along with divalinal-angiotensin iv in 12 studies

Compound Research Comparison

Studies
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Trials
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Recent Studies (post-2010)
(angiotensin ii, des-asp(1)-des-arg(2)-ile(5)-)
Studies
(divalinal-angiotensin iv)
Trials
(divalinal-angiotensin iv)
Recent Studies (post-2010) (divalinal-angiotensin iv)
3115641603

Research

Studies (12)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (41.67)18.2507
2000's3 (25.00)29.6817
2010's3 (25.00)24.3611
2020's1 (8.33)2.80

Authors

AuthorsStudies
Ball, AE; Hanesworth, JM; Harding, JW; Kramár, EA; Krebs, LT; Sardinia, MF; Wright, JW1
Harding, JW; Kramár, EA; Wright, JW1
Hanesworth, JM; Harding, JW; Slinker, BK; Yang, Q1
Handa, RK; Harding, JW; Simasko, SM1
Briand, SI; Guillemette, G; Neugebauer, W1
Armstrong, DL; Harding, JW; Phelix, CF; Wayner, MJ; Wright, JW1
Albiston, AL; Chai, SY; Lew, RA; McDowall, SG; Mustafa, T; Ye, S1
Chai, SY; Gaspari, TA; Vinh, A; Widdop, RE1
Beyer, CE; Dwyer, JM; Lin, Q; Ling, HP; Luo, B; Mark, RJ; Neal, S; Platt, BJ; Rosenzweig-Lipson, S; Schechter, LE1
Lee, KO; Sim, MK; Wong, YC1
Eans, SO; Ganno, ML; McLaughlin, JP; Mizrachi, E; Paris, JJ; Reilley, KJ1
Cheng, C; Cheng, J; Hao, P; Sui, W; Wang, X; Xing, Y; Xue, F; Zhang, C; Zhang, J; Zhang, M; Zhang, Y1

Other Studies

12 other study(ies) available for angiotensin ii, des-asp(1)-des-arg(2)-ile(5)- and divalinal-angiotensin iv

ArticleYear
Characterization of the binding properties and physiological action of divalinal-angiotensin IV, a putative AT4 receptor antagonist.
    Regulatory peptides, 1996, Dec-03, Volume: 67, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Autoradiography; Binding, Competitive; Cattle; Drug Stability; Female; Iodine Radioisotopes; Kinetics; Male; Mice; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Substrate Specificity

1996
Angiotensin II- and IV-induced changes in cerebral blood flow. Roles of AT1, AT2, and AT4 receptor subtypes.
    Regulatory peptides, 1997, Jan-29, Volume: 68, Issue:2

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Blood Flow Velocity; Blood Pressure; Cerebrovascular Circulation; Female; Imidazoles; Laser-Doppler Flowmetry; Losartan; Male; Microcirculation; Pyridines; Rats; Rats, Sprague-Dawley; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Receptors, Angiotensin; Tetrazoles

1997
The AT4 receptor agonist [Nle1]-angiotensin IV reduces mechanically induced immediate-early gene expression in the isolated rabbit heart.
    Regulatory peptides, 1997, Aug-29, Volume: 71, Issue:3

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; DNA-Binding Proteins; Gene Expression; Genes, fos; Genes, Immediate-Early; Genes, jun; Heart; In Vitro Techniques; Male; Myocardium; Rabbits; Receptors, Angiotensin; Transcription Factors

1997
Characterization and function of the bovine kidney epithelial angiotensin receptor subtype 4 using angiotensin IV and divalinal angiotensin IV as receptor ligands.
    The Journal of pharmacology and experimental therapeutics, 1999, Volume: 291, Issue:3

    Topics: Adrenal Medulla; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Calcium; Cattle; Cell Line; Cell Membrane; Cytosol; Dithiothreitol; Epithelial Cells; Guanosine 5'-O-(3-Thiotriphosphate); In Vitro Techniques; Iodine Radioisotopes; Kidney; Ligands; Liver; Male; Peptides; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin

1999
Agonist-dependent AT(4) receptor internalization in bovine aortic endothelial cells.
    Journal of cellular biochemistry, 1999, Dec-15, Volume: 75, Issue:4

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Binding Sites; Cattle; Cell Membrane; Cells, Cultured; Dose-Response Relationship, Drug; Endosomes; Endothelium, Vascular; Extracellular Space; Hypertonic Solutions; Iodine Radioisotopes; Receptors, Angiotensin; Sucrose

1999
Angiotensin IV enhances LTP in rat dentate gyrus in vivo.
    Peptides, 2001, Volume: 22, Issue:9

    Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dentate Gyrus; Dose-Response Relationship, Drug; Excitatory Postsynaptic Potentials; Long-Term Potentiation; Losartan; Male; Perfusion; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Synaptic Transmission; Time Factors

2001
Angiotensin AT4 ligands are potent, competitive inhibitors of insulin regulated aminopeptidase (IRAP).
    Journal of neurochemistry, 2003, Volume: 86, Issue:2

    Topics: Aminopeptidases; Angiotensin II; Angiotensin Receptor Antagonists; Binding, Competitive; Cell Line; Cystinyl Aminopeptidase; Enzyme Activation; Enzyme Inhibitors; Hemoglobins; Humans; Kidney; Leucine; Ligands; Oligopeptides; Peptide Fragments; Peptides; Receptors, Angiotensin; Recombinant Proteins; Substrate Specificity

2003
Angiotensin IV-evoked vasoprotection is conserved in advanced atheroma.
    Atherosclerosis, 2008, Volume: 200, Issue:1

    Topics: Angiotensin II; Angiotensin II Type 2 Receptor Blockers; Angiotensin Receptor Antagonists; Animals; Antihypertensive Agents; Atherosclerosis; Blood Pressure; Diet, Atherogenic; Disease Models, Animal; Endothelial Cells; Imidazoles; Male; Mice; Mice, Knockout; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Pyridines; Receptors, Angiotensin; Superoxides; Up-Regulation

2008
Angiotensin IV elevates oxytocin levels in the rat amygdala and produces anxiolytic-like activity through subsequent oxytocin receptor activation.
    Psychopharmacology, 2010, Volume: 209, Issue:4

    Topics: Amygdala; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Depression; Dose-Response Relationship, Drug; Exploratory Behavior; Hemoglobins; Immunoassay; Injections, Intraperitoneal; Injections, Intraventricular; Injections, Subcutaneous; Ligands; Male; Mice; Microdialysis; Oxytocin; Peptide Fragments; Rats; Rats, Sprague-Dawley; Receptors, Angiotensin; Receptors, Oxytocin; Time Factors; Up-Regulation

2010
Des-aspartate-angiotensin-I and angiotensin IV improve glucose tolerance and insulin signalling in diet-induced hyperglycaemic mice.
    Biochemical pharmacology, 2011, Nov-01, Volume: 82, Issue:9

    Topics: Angiotensin I; Angiotensin II; Animals; Blood Glucose; Cystinyl Aminopeptidase; Dietary Fats; Dietary Sucrose; Drug Administration Schedule; Glucose Intolerance; Hyperglycemia; Indomethacin; Insulin; Insulin Receptor Substrate Proteins; Janus Kinase 2; Losartan; Male; Mice; Mice, Inbred C57BL; Phosphatidylinositol 3-Kinases; Receptor, Angiotensin, Type 1; Signal Transduction

2011
Central administration of angiotensin IV rapidly enhances novel object recognition among mice.
    Neuropharmacology, 2013, Volume: 70

    Topics: Alanine; Angiotensin II; Angiotensin Receptor Antagonists; Animals; Dose-Response Relationship, Drug; Infusions, Intraventricular; Male; Mice; Motor Activity; Nootropic Agents; Recognition, Psychology; Time Factors

2013
Angiotensin IV attenuates diabetic cardiomyopathy
    Theranostics, 2021, Volume: 11, Issue:18

    Topics: Angiotensin II; Animals; Apoptosis; Autophagy; Blood Glucose; Cell Line; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Disease Models, Animal; Fibrosis; Forkhead Box Protein O1; Glucose; Male; Mice; Mice, Inbred C57BL; Myocytes, Cardiac; Oxidative Stress; Quinolones; Signal Transduction; Streptozocin; Ventricular Dysfunction, Left

2021